DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
The generic ingredient in EMGEL is erythromycin. There are one hundred and three drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Profile for product number 001
|Approval Date:||Aug 23, 1991||TE:||RLD:||No|
Complete Access Available with Subscription